Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 7385 - 7392 of 12004 results

FTC Takes Action Against D-Link for Deceptive Practices Endangering the IoT

January 13, 2017| Blog| Viewpoint

Health Care Enforcement Review And 2017 Outlook: Part 1

January 13, 2017| News

FDA Sticks to Its Naming Plan for Biologics and Biosimilars

January 13, 2017| News

When An Arbitration Clause Sounds Permissive But Is Not -- Does "May" Really Mean "Must"?

January 12, 2017| Blog| Viewpoint

Pizza! Pizza!: Little Caesar’s Repeated Term Slogans Are Not a “Family of Marks”

January 12, 2017| Blog| Viewpoint

FDA Finalizes Tobacco Product Intended Use Rules, Under a Risk of Rescission by Congress

January 12, 2017| Blog| Viewpoint

Grassley Continues To Press CMS on Medicaid Drug Rebate Classifications: What Will Be the Fallout?

January 12, 2017| Blog| Viewpoint

Supreme Court Declines to Revisit Broad Personal Jurisdiction Over ANDA Filers

January 12, 2017| Blog| Viewpoint

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases